Women Have Greater Mortality With Alcohol-Related Liver Disease

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Feb. 1, 2024 -- Women with fatty liver disease related to alcohol consumption have almost twice the risk for dying within a certain time period than men with the same condition, according to a letter to the editor published in the February issue of the Journal of Hepatology.

Hongwei Ji, from the Affiliated Hospital of Qingdao University in China, and colleagues used data from the U.S. National Health and Nutrition Examination Survey III (1988 to 1994; 10,007 participants) to examine prevalence and prognosis differences in steatotic liver disease (SLD) phenotypes by sex. Using the revised SLD nomenclature, the analysis included 1,461 participants with metabolic dysfunction-associated SLD (MASLD), 225 with metabolic dysfunction-associated and alcohol-related liver disease (MetALD), 105 with ALD, 180 with other types of SLD, and 8,036 with no SLD.

The researchers found that MASLD, MetALD, and ALD prevalence in men was 18.5 percent, 3.2 percent, and 1.7 percent, respectively, while the corresponding prevalence rates in women were 10.3 percent, 1.2 percent, and 0.3 percent. MASLD was not significantly associated with all-cause mortality for either sex. MetALD was associated with a higher risk for all-cause mortality in women (hazard ratio, 1.83), but not in men. In both sexes, the presence of ALD was significantly associated with all-cause mortality, but the magnitude was greater in women than men (hazard ratios, 3.49 versus 1.89). When considering SLD phenotypes in putative order of etiologic severity (i.e., MASLD, MetALD, then ALD), there was not a significant sex difference in prevalence across worsening phenotypes, but there was a significant sex difference in mortality risk.

“These findings are especially concerning in the context of the COVID-19 pandemic, during which alcohol use and related death, particularly in women, has increased," coauthor Alan Kwan, M.D., from Cedars-Sinai Medical Center in Los Angeles, said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-02-02 00:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords